Furthermore, the functional checkpoints of BCRP revealed that mutagenic substitution of asparagine 596, the crucial glycosylation site on BCRP, with glutamine disrupted N-linked glycosylation, interfered with localization, function of BCRP, and sensitized hitherto MDR cancer cells to chemotherapeutics (29). Here, ABCG2 is linked to cancer.